NO20020907L - Nytt responselement - Google Patents

Nytt responselement

Info

Publication number
NO20020907L
NO20020907L NO20020907A NO20020907A NO20020907L NO 20020907 L NO20020907 L NO 20020907L NO 20020907 A NO20020907 A NO 20020907A NO 20020907 A NO20020907 A NO 20020907A NO 20020907 L NO20020907 L NO 20020907L
Authority
NO
Norway
Prior art keywords
response element
new response
new
response
Prior art date
Application number
NO20020907A
Other languages
English (en)
Other versions
NO20020907D0 (no
Inventor
Isabel Climent-Johansson
Karin Dahlman-Wright
Staffan Lake
Wyeth Wasserman
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9903009A external-priority patent/SE9903009D0/xx
Priority claimed from SE9904269A external-priority patent/SE9904269A0/sv
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Publication of NO20020907D0 publication Critical patent/NO20020907D0/no
Publication of NO20020907L publication Critical patent/NO20020907L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20020907A 1999-08-26 2002-02-25 Nytt responselement NO20020907L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9903009A SE9903009D0 (sv) 1999-08-26 1999-08-26 Use of new responsive elements
US15186799P 1999-08-31 1999-08-31
SE9904269A SE9904269A0 (en) 1999-08-26 1999-11-25 Use of new responsive elements
PCT/SE2000/001603 WO2001014544A1 (en) 1999-08-26 2000-08-22 Novel response element

Publications (2)

Publication Number Publication Date
NO20020907D0 NO20020907D0 (no) 2002-02-25
NO20020907L true NO20020907L (no) 2002-02-25

Family

ID=27355988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020907A NO20020907L (no) 1999-08-26 2002-02-25 Nytt responselement

Country Status (6)

Country Link
US (2) US6472515B1 (no)
EP (1) EP1206533A1 (no)
AU (1) AU6884200A (no)
CA (1) CA2380865A1 (no)
NO (1) NO20020907L (no)
WO (1) WO2001014544A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2380865A1 (en) * 1999-08-26 2001-03-01 Biovitrum Ab Novel response element
US7935788B2 (en) * 2004-10-04 2011-05-03 National Research Council Of Canada Reverse cumate repressor mutant
EP1797186B1 (en) * 2004-10-04 2016-05-25 National Research Council Of Canada Expression system, components thereof and methods of use
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
BRPI0716959A2 (pt) 2006-09-26 2013-10-29 Infectious Disease Res Inst Composição de vacina contendo adjuvante sintético
EP3124491B1 (en) 2009-06-05 2019-10-30 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants and vaccine compositions as well as pharmaceutical compositions containing them
EP3632463A1 (en) 2011-04-08 2020-04-08 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
PL2811981T3 (pl) 2012-02-07 2019-09-30 Infectious Disease Research Institute Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
NZ701881A (en) 2012-05-16 2016-10-28 Immune Design Corp Vaccines for hsv-2
MX370573B (es) 2013-04-18 2019-12-17 Immune Design Corp Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
JP7195148B2 (ja) 2016-05-16 2022-12-23 アクセス ツー アドバンスト ヘルス インスティチュート Ｔｌｒアゴニストを含有する製剤及び使用方法
WO2017210364A1 (en) 2016-06-01 2017-12-07 Infectious Disease Research Institute Nanoalum particles containing a sizing agent
WO2019051149A1 (en) 2017-09-08 2019-03-14 Infectious Disease Research Institute LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0846761A1 (en) * 1996-12-09 1998-06-10 Introgene B.V. A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
CA2380865A1 (en) * 1999-08-26 2001-03-01 Biovitrum Ab Novel response element

Also Published As

Publication number Publication date
EP1206533A1 (en) 2002-05-22
WO2001014544A1 (en) 2001-03-01
AU6884200A (en) 2001-03-19
NO20020907D0 (no) 2002-02-25
US20030143583A1 (en) 2003-07-31
CA2380865A1 (en) 2001-03-01
US6472515B1 (en) 2002-10-29

Similar Documents

Publication Publication Date Title
DE60026748D1 (de) Thermostat
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
ATE449265T1 (de) Verbindungselement
DE60101126D1 (de) Tintenstrahlaufzeichnungselement
NO20020907D0 (no) Nytt responselement
DE60102606D1 (de) Tintenstrahlaufzeichnungselement
DE60014306D1 (de) Tintenstrahlaufzeichnungselement
DE59905139D1 (de) Strukturelement
DE60039385D1 (de) Magnetwiderstandselement
FI990800A0 (fi) Verkkoelementti
ATA60999A (de) Wandelement
DE60043762D1 (de) Schutzelement
DE60017345D1 (de) Tintenstrahlaufzeichnungselement
NO20022927L (no) Substituerte pyrrazoler
DE60101705D1 (de) Tintenstrahlaufzeichnungselement
DE29905123U1 (de) Plattenförmiges Element
DE50014502D1 (de) Verbindungselement
DE29906262U1 (de) Federelement
ATA189999A (de) Verbindungselement
DE29902507U1 (de) Halteelement
DE29907495U1 (de) Kontaktelement
DK1200423T3 (da) Substituerede pehnyluraciler
AT3887U3 (de) Verdampfungselement
ATA90299A (de) Wandelement